BNP Paribas Maintains Neutral on AbbVie, Raises Price Target to $247

Benzinga · 2d ago
BNP Paribas analyst Navann Ty maintains AbbVie (NYSE:ABBV) with a Neutral and raises the price target from $218 to $247.